Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019–positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system

[1]  M. Crowther,et al.  Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study , 2020, Blood Advances.

[2]  Jane A. Linderbaum,et al.  Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic , 2020, Mayo Clinic Proceedings.

[3]  Yaping Dai,et al.  Associations between serum amyloid A, interleukin‐6, and COVID‐19: A cross‐sectional study , 2020, Journal of clinical laboratory analysis.

[4]  D. Gupta,et al.  Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies , 2020, Heliyon.

[5]  Ying-feng Lu,et al.  A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19 , 2020, International Journal of Infectious Diseases.

[6]  M. Di Nisio,et al.  Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis , 2020, Thrombosis Research.

[7]  W. Ge,et al.  Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis , 2020, Frontiers in Cardiovascular Medicine.

[8]  G. Bauer,et al.  Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation , 2020, Medical Hypotheses.

[9]  R. Curci,et al.  Characteristics of Venous Thromboembolism in COVID-19 Patients: A Multicenter Experience from Northern Italy , 2020, Annals of Vascular Surgery.

[10]  I. Abdullahi,et al.  Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions , 2020, Journal of Taibah University Medical Sciences.

[11]  Gilbert GREUB,et al.  Venous thromboembolism in critically Ill patients with COVID‐19: Results of a screening study for deep vein thrombosis , 2020, Research and Practice in Thrombosis and Haemostasis.

[12]  M. Aepfelbacher,et al.  Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.

[13]  B. Lambrecht,et al.  Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial , 2020, Trials.

[14]  P. Wells,et al.  Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 , 2020, Chest.

[15]  N. Rezaei,et al.  Interleukin-6 and severe COVID-19: a systematic review and meta-analysis , 2020, European Cytokine Network.

[16]  M. Aepfelbacher,et al.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.

[17]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[18]  L. Beenen,et al.  Incidence of venous thromboembolism in hospitalized patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[19]  E. Marone,et al.  Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations , 2020, Journal of Vascular Surgery: Venous and Lymphatic Disorders.

[20]  T. Wakefield,et al.  Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic , 2020, Journal of Vascular Surgery: Venous and Lymphatic Disorders.

[21]  E. Coomes,et al.  Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis , 2020, medRxiv.

[22]  D. Baidya,et al.  Epidemiological & clinical characteristics & early outcome of COVID-19 patients in a tertiary care teaching hospital in India: A preliminary analysis , 2020, The Indian journal of medical research.

[23]  A. Kotanidou,et al.  Determinants of prolonged intensive care unit stay in patients after cardiac surgery: a prospective observational study. , 2017, Journal of thoracic disease.

[24]  T. Steiner,et al.  The impact of low hemoglobin levels and transfusion on critical care patients with severe ischemic stroke: STroke: RelevAnt Impact of HemoGlobin, Hematocrit and Transfusion (STRAIGHT)--an observational study. , 2014, Journal of critical care.